Avantor Shares Outstanding 2018-2023 | AVTR
Avantor shares outstanding history from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Avantor shares outstanding for the quarter ending December 31, 2023 were 0.678B, a 0.15% decline year-over-year.
- Avantor 2023 shares outstanding were 0.678B, a 0.15% decline from 2022.
- Avantor 2022 shares outstanding were 0.679B, a 13.31% increase from 2021.
- Avantor 2021 shares outstanding were 0.6B, a 2.78% increase from 2020.
| Avantor Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 678 |
| 2022 | 679 |
| 2021 | 600 |
| 2020 | 583 |
| 2019 | 401 |
| 2018 | 133 |
| 2017 | 151 |
| Avantor Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 678 |
| 2023-09-30 | 679 |
| 2023-06-30 | 675 |
| 2023-03-31 | 678 |
| 2022-12-31 | 679 |
| 2022-09-30 | 679 |
| 2022-06-30 | 680 |
| 2022-03-31 | 681 |
| 2021-12-31 | 600 |
| 2021-09-30 | 598 |
| 2021-06-30 | 591 |
| 2021-03-31 | 589 |
| 2020-12-31 | 583 |
| 2020-09-30 | 577 |
| 2020-06-30 | 582 |
| 2020-03-31 | 581 |
| 2019-12-31 | 401 |
| 2019-09-30 | 581 |
| 2019-06-30 | 323 |
| 2019-03-31 | 133 |
| 2018-12-31 | |
| 2018-09-30 | 133 |
| 2018-06-30 | 133 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.968B | $6.967B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.410B | 15.86 |
| Cencora (COR) | United States | $44.248B | 17.25 |
| ICON (ICLR) | Ireland | $26.054B | 24.60 |
| DiDi Global (DIDIY) | China | $22.390B | 0.00 |
| CochLear (CHEOY) | Australia | $14.783B | 0.00 |
| Revvity (RVTY) | United States | $13.383B | 23.48 |
| Natera (NTRA) | United States | $13.324B | 0.00 |
| Viatris (VTRS) | United States | $13.121B | 3.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.374B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.185B | 40.09 |
| Charles River Laboratories (CRL) | United States | $11.577B | 22.17 |
| Solventum (SOLV) | United States | $10.632B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.727B | 50.26 |
| Organon (OGN) | United States | $5.534B | 5.25 |
| Bausch + Lomb (BLCO) | Canada | $5.357B | 21.47 |
| Doximity (DOCS) | United States | $4.429B | 30.83 |
| PACS (PACS) | United States | $4.249B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.362B | 30.76 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $3.106B | 32.54 |
| GoodRx Holdings (GDRX) | United States | $3.024B | 115.14 |
| Progyny (PGNY) | United States | $2.623B | 45.16 |
| NovoCure (NVCR) | Jersey | $2.386B | 0.00 |
| Agilon Health (AGL) | United States | $2.295B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.244B | 8.89 |
| Teladoc Health (TDOC) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.073B | 8.87 |
| BrightSpring Health Services (BTSG) | United States | $1.953B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.595B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.336B | 0.00 |
| Embecta (EMBC) | United States | $0.819B | 5.57 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.656B | 6.96 |
| Auna S.A (AUNA) | Luxembourg | $0.632B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.627B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.546B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.519B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.419B | 41.75 |
| ModivCare (MODV) | United States | $0.396B | 7.41 |
| MultiPlan (MPLN) | United States | $0.385B | 0.00 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| DocGo (DCGO) | United States | $0.325B | 17.78 |
| Ascend Wellness Holdings (AAWH) | United States | $0.289B | 0.00 |
| Sharecare (SHCR) | United States | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| Biodesix (BDSX) | United States | $0.179B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.80 |
| Oncology Institute (TOI) | United States | $0.050B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| OncoCyte (OCX) | United States | $0.025B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |